Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis
Article in Arthritis & Rheumatology (January 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Arthritis & Rheumatology (January 2024)
Article in International Journal of Molecular Sciences (July 2023)
Article in Rheumatology International (April 2023)